| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 54,099 | 53,757 | 53,591 | 62,980 | | Cost of Revenue | 45,211 | 45,022 | 46,102 | 53,850 | | | Gross Profit | 8,888 | 8,735 | 7,489 | 9,130 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,223 | 5,012 | 5,031 | 4,881 | | Non Recurring |
-
| 10,163 |
-
| 5,508 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,665 | (6,440) | 2,458 | (1,259) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 107 | 61 | 151 | 476 | | Earnings Before Interest And Taxes | 3,772 | (6,379) | 2,609 | (783) | | Interest Expense | 52 | 50 | 55 | 78 | | Income Before Tax | 3,720 | (6,429) | 2,554 | (861) | | Income Tax Expense | 1,737 | 190 | 1,095 | 70 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,983 | (6,619) | 1,459 | (931) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,983 | (6,619) | 1,459 | (931) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,983 | ($6,619) | $1,459 | ($931) |
|
0.47% Nasdaq 
Income Statement
